Development of Radiological/Nuclear Medical Countermeasures (MCMs) And Biodosimetry Devices

The National Institute of Allergy and Infectious Diseases (NIAID) is issuing Broad Agency Announcement 75N93026R00004 for a multi‑year (up to three years; base period of one year with two one‑year options) research and product‑development effort. Offerors must submit a technical proposal that includes a two‑part Statement of Work (Scope and Technical Requirements) following the provided outline. The work will encompass a product development plan covering research and development (efficacy/validation, animal or non‑animal model studies, pharmacology/toxicology, biodosimetry signatures), manufacturing and CMC development, and FDA IND‑ or IUO‑enabling activities, together with regulatory compliance, quality assurance, and data‑management functions. Proposals must also address biohazard, controlled‑substance, and IT‑security safeguards; a comprehensive subcontracting plan that details small‑business participation, indirect‑cost allocation, and the subcontracting‑program administrator; staffing and facility resources; and inclusion of women and minorities in the study population. Evaluation will focus on the offeror’s demonstrated technical capability, feasibility of implementation, and price reasonableness per FAR 15.404. While the solicitation incorporates standard FAR clauses (full text available at acquisition.gov), no budget cap is provided; an average annual cost estimate is included in Attachment 3. Offerors should prepare their submission through the Electronic Contract Proposal Submission Platform and may request guidance on profile creation.

Notice ID

d5bac18d4f6e4707ac3c2fa1d8e873ba

Solicitation Number

BAA-75N93026R00004

NAICS Code

541715

Classification Code

AN12